Top Markets
Coin of the day
Allgens Medical Technology Co. Ltd. Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613
Classement en actions #16116
Allgens Medical Technology Co. Ltd. operates as a medical device firm,... Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
Prix de l'action
$2.28
Capitalisation boursière
$312.51M
Changement (1 jour)
0.70%
Changement (1 an)
-21.04%
Pays
CN
Échange Allgens Medical Technology Co. Ltd. (688613)

Catégorie

Historique du rendement du dividende pour Allgens Medical Technology Co. Ltd. (688613)
Le rendement du dividende (TTM) de Allgens Medical Technology Co. Ltd. (symbole boursier : 688613) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Allgens Medical Technology Co. Ltd. (688613) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes